Cycling cancer persister cells arise from lineages with distinct programsYaara Oren, Aviv Regev, Michael S. Cuoco et al.|Nature|2021Cited by 514
ASCL1 Drives Tolerance to Osimertinib in <i>EGFR</i> Mutant Lung Cancer in Permissive Cellular ContextsBomiao Hu, Katerina Politi|Cancer Research|2024Cited by 24